Psoriasis,T Cells and Autoimmunity

Psoriasis Fry L. . Br J Dermatol 1988; 119: 445–61

Barker JNWN . The pathophysiology of psoriasis. Lancet 1991; 338: 227–30

Bjerke J.R. , Krough H.K. , Matre R. . Characterisation of mononuclear cell infiltrate in psoriatic lesions. J Invest Dermatol 1978; 71: 340

Valdimarsson H. , Baker B.S. , Jonsdottir I. , Fry L. . Psoriasis: a disease of abnormal keratinocyte proliferation induced by T lymphocytes. Immunol Today 1986; 7: 256–9

Gottlieb S.L. , Gilleaudeau P. , Johnson R. Response of psoriasis to a lymphocyte-selective toxin (OAB₃₈₉IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Nature Med 1995; 1: 442–7

de Boer O.J. , van der Loos C.M. , Hamerlinck F. , Bos J.D. , Das P.K. . Reappraisal of in situ immunophenotypic analysis of psoriasis skin: interaction of activated HLA-DR⁺ immunocompetent cells and endothelial cells is a major feature of psoriatic lesions. Arch Dermatol Res 1994; 286: 87–96

Barker JNWN , Karabin G.D. , Stoof T.J. , Sarma V.J. , Dixit V.M. , Nickoloff B.J. . Detection of interferon-gamma MRNA in psoriatic epidermis by polymerase chain reaction. J Dermatol Sci 1991; 2: 106–11

Morganroth G.S. , Chan L.S. , Weinstein G.D. , Voorhees J.J. , Cooper K.D. . Proliferating cells in psoriatic dermis are comprised primarily of T cells, endothelial cells, and factor XIIIa⁺ perivascular dendritic cells. J Invest Dermatol 1991; 96: 333–40

Mossman T.R. , Cherwinski H. , Bond M.W. , Giedlin M.A. , Coffman R.L. . Two types of murine helper T cell clones I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986; 136: 2348–57

Modlin R.L. . Th₁-Th₂ paradigm: insights from leprosy. J Invest Dermatol 1994; 102: 828–32

Saed G. , Fivenson D.P. , Naidu Y. , Nickoloff B.J. . Mycosis fungoides exhibits a TH1 cell-mediated cytokine profile whereas Sezary syndrome expresses a TH2-type profile. J Invest Dermatol 1994; 103: 29–33

Kay A.B. , Ying S. , Varney V. Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte/macrophage colony stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects. J Expl Med 1991; 173: 775–8

Uyemura K. , Yamamura M. , Fivenson D.F. , Modlin R.L. , Nickoloff B.J. . The cytokine network in lesional and lesion-free psoriatic skin is characterised by a T-helper type 1 cell-mediated response. J Invest Dermatol 1993; 101: 701–5

Schlaak J.F. , Buslau M. , Jochum W. T cells involved in psoriasis vulgaris belong to the Th₁ subset. J Invest Dermatol 1994; 102: 145–9

Henseler T. , Christophers E. . Disease concomitance in psoriasis. J Am Acad Dermatol 1995; 32: 982–6

Valdimarsson H. , Baker B.S. , Jonsdottir I. , Powles A. , Fry L. . Psoriasis: a T-cell-mediated autoimmune disease induced by streptococcal superantigens? Immunol Today 1995; 16: 145–9

Telfer N.R. , Chalmers R.J.C. , Whale K. , Colman G. . The role of streptococcal infection in the initiation of guttate psoriasis. Arch Dermatol 1992; 126: 39–42

Robinson J.H. , Atherton M.C. , Goodacre J.A. , Pinkney M. , Weightman H. , Kehoe M.A. . Mapping T-cell epitopes in group A streptococcal type 5 M protein. Infect Immunol 1991; 59: 4324–31

Drake C.G. , Kotzin B.L. . Superantigens: biology, immunology, and potential role in disease. J Clin Immunol 1992; 12: 149–62

McFadden J. , Valdimarsson H. , Fry L. . Cross-reactivity between streptococcal M surface antigen and human skin. Br J Dermatol 1991; 125: 343–7

Swerlick R.A. , Cunningham M.W. , Hall N.K. . Monoclonal antibodies cross-reactive with group A streptococci and normal and psoriatic human skin. J Invest Dermatol 1986; 87: 367–71

Leung D.Y.M. , Walsh P. , Giorno R. , Norris D.A. . A potential role for superantigens in the pathogenesis of psoriasis. J Invest Dermatol 1993; 100: 225–8

Lewis H.M. , Baker B.S. , Bokth S. Restricted T-cell receptor Vβ gene usage in the skin of patients with guttate and chronic plaque psoriasis. Br J Dermatol 1993; 129: 514–20

Chang J.C.C. , Smith L.R. , Froning K. CD8⁺ T cells in psoriatic lesions preferentially use T-cell receptor V_β³ and/or V_β13.1 genes. Proc Natl Acad Sci USA 1994; 91: 9282–6

Boehncke W-H , Dressel D. , Manfras B. T-cell-repertoire in chronic plaque-stage psoriasis is restricted and lacks enrichment of superantigen-associatcd Vβ regions. J Invest Dermatol 1995; 104: 725–8

Farber E.M. , Nall M.L. , Watson W. . Natural history of psoriasis in 61 twin pairs. Arch Dermatol 1974; 109: 207–11

Lomholt G. . Psoriasis, Prevalance, Spontaneous Course and Genetics. Copenhagen: BEC Bads Boghandel, 1963

Tomfohrde J. , Silverman A. , Barnes R. Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q. Science 1994; 264: 1141–5

Nair R.P. , Guo S.W. , Janish S. Scanning chromosome 17 for psoriasis susceptibility: lack of evidence for a distal 17q locus. Hum Heredity 1995; 45: 219–30

Henseler T. , Christophers E. . Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol 1985; 13: 450

Henseler T. , Elder J.T. , Nair R. Psoriasis and HLA-Cw7 in a Caucasian family: role of alanine 73. J Invest Dermatol 1995; 104: 598

Nair R.P. , Jenisch S. , Guo S.W. Evidence for psoriasis susceptibility gene(s) on human chromosome 6p. J Invest Dermatol 1995; 104: 598

Jenisch S. , Henseler T. , Westphal E. HLA-DQ9 9DQB1^*0303) increases susceptibility to type I psoriasis in multiplex families but only in the presence of HLA-Cw6. J Invest Dermatol 1995; 104: 629

Schwartz R.H. . A cell culture model for T lymphocyte clonal anergy. Science 1990; 248: 1349–56

Nestle F.O. , Turka L.A. , Nickoloff B.J. . Characterization of dermal dendritic cells in psoriasis. J Clin Invest 1994; 94: 202–9

Nickoloff B.J. , Turka L.A. . Immunological functions of non-professional antigen-presenting cells: new insights from studies of T-cell interactions with keratinocytes. Immunol Today 1994; 15: 464–9

Nickoloff B.J. , Nestle F.O. , Zheng X-G , Turka L.A. . T lymphocytes in skin lesions of psoriasis and mycosis fungoides express B7-1: a ligand for CD28. Blood 1994; 83: 2580–6

Baadsgaard O. , Tong P. , Elder J.T. UM4D4 (CD60) T cells are compartmentalized into psoriatic skin and release lymphokines that induce a keratinocyte phenotype expressed in psoriatic lesions. J Invest Dermatol 1990; 95: 275–82

Weiner H.L. , Mackin G.A. , Matsui M. Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science 1993; 259: 1321–4

Nayler-Anderson C. , Bober L.A. , Robinson M.E. , Siskind G.W. , Thorbecke G.J. . Suppression of type II collagen-induced arthritis by intragastic administration of soluble II collagen. Proc Natl Acad Sci USA 1986; 83: 7443–6

Bata-Csorgo Z. , Hammerberg C. , Voorhees J.J. , Cooper K.D. . Flow cytometric indentification of proliferative subpopulations within normal human epidermis and the localization of the primary hyperproliferative population in psoriasis. J Expl Med 1993; 178: 1271–81

Bata-Csorgo Z. , Hammerberg C. , Voohees J.J. , Cooper K.D. . Kinetics and regulation of human keratinocyte stem cell growth in short-term primary ex vivo culture. J Clin Invest 1995; 95: 317–27

Strange P. , Cooper K.D. , Hansen E.R. T-lymphocyte clones initiated from lesional psoriatic skin release growth factors that induce keratinocyte proliferation. J Invest Dermatol 1993; 101: 695–700

Griffiths C.E.M. , Voohees J.J. , Nickoloff B.J. . Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin. Modulation by recombinant gamma interferon and tumour necrosis factor. J Am Acad Dermatol 1989; 20: 617

Groves R.W. , Allen M.H. , Barker JNWN , Haskard D.O. , MacDonald D.M. . Endothelial leukocyte adhesion molecule-1 (ELAM-1) expression in cutaneous inflammation. Br J Dermatol 1991; 124: 117–23

Wakita H. , Takigawa M. . E-selectin and vascular cell adhesion molecule-1 are critical for initial trafficking of helper-inducer memory T cells in psoriatic plaques. Arch Dermatol 1994; 130: 457–63

Picker L.J. , Treer J.R. , Ferguson-Darnell B. , Collins P.A. , Bergstresser P.R. , Terstappen LWMM . Control of lymphocyte recirculation in man, II: differential regulation of the cutaneous lymphocyte associated antigen, a tissue-selective homing receptor for skin-homing T cells. J Immunol 1993; 150: 1122–36

Griffiths C.E.M. , Powles A.V. , Leonard J.N. , Baker B.S. , Fry L. , Valdimarsson H. . Clearance of psoriasis with low dose cyclosporin. BMJ 1986; 293: 731–2

Ellis C.N. , Fradin M.S. , Messana J.M. Cyclosporine for plaque type psoriasis. Results of a multidose, double-blind trial. N Engl J Med 1991; 324: 277

Jegasothy B.V. , Ackerman C.D. , Todo S. , Fung J.J. , Abu-Elmayd K. , Starzl T.E. . Tacrolimus (FK506)–a new therapeutic agent for severe recalcitrant psoriasis. Arch Dermatol 1991; 128: 781–5

Emmel E.A. , Verweije C.L. , Durand D.B. , Higgins K.M. , Lacy E. , Crabtree G.R. . Cyclosporin A specifically inhibits function of nuclear proteins involved in T cell activation. Science 1989; 246: 1617

Elder J.T. , Hammerberg C. , Cooper K.D. Cyclosporin A rapidly inhibits epidermal cytokine expression in psoriasis lesions, but not in cytokine-stimulated cultured keratinocytes. J Invest Dermatol 1993; 101: 761–6

Poizot-Martin I. , Dhiver C. , Mawas C. , Olive D. , Gastraut J.A. . Are CD4 antibodies and peptide T new treatments for psoriasis? Lancet 1991; 337: 1477

Prinz J. , Braun Falco O. , Meurer M. Chimaeric CD4 monoclonal antibody in treatment of generalised pustular psoriasis. Lancet 1991; 338: 320

Weinshenker B.G. , Bass B.H. , Ebers G.C. , Rice G.P.A. . Remission of psoriatic lesions with muromonab-CD3 (orthoclone OKT3) treatment. J Am Acad Dermatol 1989; 20: 1132–3

Hanifin J. , Schneider L.C. , Leung D.Y.M. Recombinant interferon gamma therapy for atopic dermatitis. J Am Acad Dermatol 1993; 28: 189–97

Griffiths T.W. , Griffiths C.E.M. , Voorhees J.J. . Immunopathogenesis and immunotherapy of psoriasis. Dermatol Clin 1995; 13: 739–50

Evans R.M. . The steroid and thyroid hormone receptor superfamily. Science 1988; 240: 889–95

Guyre P.M. , Girard M.T. , Morgarelli P.M. Glucocorticoid effects on the production and actions of immune cytokines. J Steroid Biochem 1988; 30: 89–93

Barnes P.J. , Adcock I. . Anti-inflammatory actions of steroids: Molecular mechanisms. Trends Pharmacol Sci 1993; 14: 436–41